Skip to content

ARKIArk Diet Q2 Buffer ETF

Grow my moneyDiversifierNewRanked #237 of 240 in this goal

Capital appreciation with a measure of downside protection.

By ARK ETF Trust · Launched 2026

Annual Cost

0.89%

#4,486 of 5,562 · expensive

Fund Size

$1M

#5,444 of 5,562 · small

Return (1Y)Goal

N/A

Track Record

2 months

#5,362 of 5,562 · young

Performance

Total-return NAV · USD
Growth of $10,000
$10,805+8.0%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Alternative

Strategy

Structured outcome

What it actually holds

By weight

Concentration

Top 1 holdings = 107.3% of fundconcentrated

ARK Innovation ETFARKK
107.3%

Asset allocation

Stocks
96.8%
Other
2.6%
Cash
0.6%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
N/A
Max drawdown
-6.6%Mild

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Where to buy

Listing

Exchange
Cboe BZX, NYSE American

Full fund details

Objective
Capital appreciation with a measure of downside protection.
Strategy
Actively managed ETF providing 50% downside participation in the ARK Innovation ETF and maximum upside participation above a 5% hurdle rate. Designed for defined outcomes over a 12-month period.
Inception date
April 1, 2026
Fund family
ARK ETF Trust

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Buffer
Warning

Buffer ETF — downside protection at a cost

Defined-outcome funds cap upside (typically 8–20%) in exchange for partial downside protection (9–30%), priced via options. Fees are materially higher than the underlying index (often 0.70%+ vs 0.03–0.10%). For most pre-retirees, a simple stock/bond mix achieves similar downside behaviour at a fraction of the cost.

Source: Morningstar, 'Defined-Outcome ETFs: Useful or Uneconomic?' (2023)

Why we flagged this: strategy=structured_outcome + structured_outcome_strategy

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've reviewed ARKI. Save it to your watchlist to track it alongside the other funds you're weighing.

Data updated on 2026-06-19